Analysis of Acute Transfusion Reactions and Their Occurrence Times

URI http://repository.lib.tottori-u.ac.jp/Repository/metadata/5547
本文ファイル
タイトル
Analysis of Acute Transfusion Reactions and Their Occurrence Times
タイトル読み
タイトルその他
著者
著者 Hatayama Yuki
著者読み
著者英語Author Hatayama Yuki
所属Affiliation Division of Clinical Laboratory, Tottori University Hospital / Division of Clinical Laboratory Medicine, Department of Pathophysiological and Therapeutic Science, School of Medicine, Tottori University Faculty of Medicine
著者 Matsumoto Satoko
著者読み
著者英語Author Matsumoto Satoko
所属Affiliation Division of Clinical Laboratory, Tottori University Hospital
著者 Hamada Eiko
著者読み
著者英語Author Hamada Eiko
所属Affiliation Division of Clinical Laboratory, Tottori University Hospital
著者 Kojima Nao
著者読み
著者英語Author Kojima Nao
所属Affiliation Division of Clinical Laboratory, Tottori University Hospital
著者 Hara Ayako
著者読み
著者英語Author Hara Ayako
所属Affiliation Division of Clinical Laboratory, Tottori University Hospital
著者 Hino Norihiko
著者読み
著者英語Author Hino Norihiko
所属Affiliation Division of Clinical Laboratory, Tottori University Hospital / Division of Blood Transfusion, Tottori University Hospital
著者 Motokura Toru
著者読み
著者英語Author Motokura Toru
所属Affiliation Division of Clinical Laboratory Medicine, Department of Pathophysiological and Therapeutic Science, School of Medicine, Tottori University Faculty of Medicine
キーワード
acute transfusion reaction
blood transfusion
hemovigilance
occurrence time
NDC分類
4類 自然科学
内容

Acute transfusion reactions (ATRs) are significantly relevant to the morbidity and mortality of patients. ATRs are mostly not severe and rarely cause severe conditions, including anaphylactic shock. The aim of this study was to clarify the frequency of ATRs and the time of event occurrence. A total of 18,745 transfusions were administered to 11,718 patients during a 3-year period. Adverse reactions including at least one sign or symptom were collected through a report system in 143 of 2,478 (5.7%) platelet concentrate transfusions, 105 of 6,629 (1.6%) red blood cell component transfusions and 51 of 2,307 (2.2%) fresh frozen plasma transfusions. Allergic signs and symptoms accounted for 70% of all adverse events. Severe signs and symptoms were observed in 7.1% of patients. These events appeared significantly earlier than those of non-severe signs and symptoms (median time 20 min vs 100 min, P < 0.05). For patients who have had repetitive transfusion-associated adverse events, preventive treatments for adverse events should be proactively promoted.

出版者
Tottori University Faculty of Medicine
資料タイプ
紀要論文
外部リンク
ISSN/ISBN
0513-5710
書誌ID
AA00892882
掲載誌・書籍タイトル
Yonago Acta Medica
61
1
開始ページ
87
終了ページ
90
発行日
2018-03-28
DOI
出版社版
著作権表記
掲載情報

Yonago Acta Medica. 2018, 61(1), 87-90

学部学科区分
医学研究科・医学部
本文言語
英語
Copyright(C)2008 Tottori University. All Rights Reserved.